during verbal (shiritori and word production) tasks was compared among schizophrenia outpatients attending our hospital before and after one-year administration of LAI antipsychotics, those treated with conventional oral drugs. Methods: Subjects were 15 schizophrenic outpatients (32.6 ± 7.7 years old) attending Kurume University Hospital diagnosed by ICD-10 and age-matched 15 healthy subjects. Symptoms were evaluated using PANSS.
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Oxy-Hb value during the tasks were measured at bilateral recording points (22 on each side) using a multi-channel NIRS system. The subjects were instructed to phonate "a-i-u-e-o" for 12 seconds as a resting condition, and performed a verbal production task (VPT) or shiritori task (saying a word starting with the last syllable). The shiritori task involved two task patterns, i.e., standard shiritori (VST) and living creatures shiritori (VLT). From the data obtained at each measurement point during the 20 trials, an averaged waveform was prepared, and peak values of waveform were calculated and analyzed. Results: On comparison between before and after LAI antipsychotics administration, PANSS score significantly decreased after one year. No significant difference was noted in the number of words in the verbal tasks between before and after administration. Oxy-Hb value was significantly increased in the left frontal region after one-year administration compared with that before administration during the VST and VPT, but no significant change was noted in the VLT. On self-evaluation, 11 patients and all families evaluated that it was good to use LAI antipsychotics. Discussion: It was suggested that LAI antipsychotics are effective, and oxy-Hb value on NIRS serves as a useful psychophysiological index to evaluate drugs.
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Qantitative EEG as a predictor of prognosis in First Episode psychosis 
While the high prevalence of concomitant cannabis and nicotine use in schizophrenia (SZ) has been viewed as a form of self-medication for cognitive and stress/emotional processing, the interaction of these substances has received limited study in terms of sensory/cognitive processes. The objective of this study was to assess the acute effects of nabilone (synthetic version of THC) and nicotine on the mismatch negativity (MMN) event-related potential, and to evaluate cannabinoid-nicotinic receptor interactions within a pilot study using healthy controls. Methods: 20 male non-smokers and non-cannabis-users were assessed using a 5-stimulus 'optimal' multi-feature MMN paradigm within a randomized, double-blind design (placebo; nabilone [0.5 mg]; nicotine [6 mg]; and nicotine + nabilone). The MMN was quantified in the time domain and the time-frequency domain. Results: The separate and combined effects of nicotine and nabilone were region-and deviant-dependent. Temporally, the MMN was impaired by nabilone and nicotine separately, whereas co-administration resulted in no impairment. Frontally, the MMN was enhanced by co-administration of nicotine and nabilone. Nabilone and the combination treatment decreased frontal evoked theta power. Conclusions: It is possible that 1) cannabinoid and nicotinic receptor systems in the frontal and auditory cortex regulating sensory processes are differentially affected, and/or 2) the functional connectivity between the two MMN generators is differentially affected by the two interacting systems. Given the high prevalence rates of tobacco and cannabis use in SZ, understanding the effect of these substances and their interactions on early sensory processes underlying higher-order cognitive processes is of clinical and scientific relevance. Research supported by the Natural Sciences and Engineering Research Council of Canada (Grant #:210572-152799-2001) .
